Alerts will be sent to your verified email
Verify EmailKLGCAP
KLG Capital Services
|
Asia Capital
|
Amerise Biosciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-0.25 % | 4.51 % | -0.9 % |
5yr average Equity Multiplier
|
1.6 | 1.17 | 1.27 |
5yr Average Asset Turnover Ratio
|
0.06 | 0.09 | 0.15 |
5yr Avg Net Profit Margin
|
-2.47 % | 41.57 % | 1.22 % |
Price to Book
|
0.67 | 0.97 | 0.93 |
P/E
|
0.0 | 16.89 | 97.08 |
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 0.0 |
Inventory Days
|
0.0 | 0.0 | 0.0 |
Days Receivable
|
0.0 | 0.0 | 0.0 |
Days Payable
|
0.0 | 0.0 | 275.57 Days |
5yr Average Interest Coverage Ratio
|
14.95 | 0.0 | -475.34 |
5yr Avg ROCE
|
-0.16 % | 6.11 % | -0.92 % |
5yr Avg Operating Profit Margin
|
-4.36 % | 56.18 % | -0.04 % |
5 yr average Debt to Equity
|
0.09 | 0.15 | 0.01 |
5yr CAGR Net Profit
|
5.92 % | -2.76 % | 0.0 |
5yr Average Return on Assets
|
-0.17 % | 3.89 % | -1.74 % |
Shareholdings
|
|||
Promoter Holding
|
60.46 % | 75.0 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
KLG Capital Services
|
Asia Capital
|
Amerise Biosciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|